FindTrial
Sign In

Appropriate use of antibiotics and its effectiveness in patients treatment

A study analyzing the impact of AMS implementation on outcomes and consumption of antibiotics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/017123
Enrollment
400
Registered
2019-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B968- Other specified bacterial agents as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Max hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pateints who are admitted in medical ICUs and wards having bacterial infections of blood, urinary tract,respiratory tract or skin and soft tissues and were started with empirical antibiotics with culture positive micribiology reports.

Exclusion criteria

Exclusion criteria: less than 18 yrs and pregnant females are excluded

Design outcomes

Primary

MeasureTime frame
â?¢ Day of therapy (DOT) is total days of patient on antibiotics treatment divided by the total number of the patient bed-days (denominator could be 100 for this study period). â?¢ Length of stay in the hospital (LOS) Antibiotics consumption measurement DDD/100 pateint days Timepoint: for 6 months—

Secondary

MeasureTime frame
Appropriate empiric treatmentbased on culture results Rate of de-escalation of antibioticsTimepoint: For 6 months—

Countries

India

Contacts

Public ContactDr Bansidhar Tarai

Max Hospital

bansidhar.tarai@maxhealthcare.com9971020844

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026